This stylish bean-to-cup machine excels at the basics, making pulling perfect shots as easy as pressing a button.
Cantor Fitzgerald analyst Charles Duncan initiated coverage of GH Research (GHRS) with an Overweight rating and no price target GH Research is ...
Canaccord analyst Sumant Kulkarni lowered the firm’s price target on Cybin (CYBN) to $73 from $86 and keeps a Buy rating on the shares. The ...
DMT's take on the knitted shoe, which works well for relaxed rides and longer distances but lacks support for hard efforts ...
Aya will release its fourth quarter and full year 2024 financial and operational results before market open on March 28, 2025 and will host a conference call shortly afterwards. Details of the call ...
Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, announced that its wholly owned subsidiary, Algernon NeuroScience (AGN Neuro), has appointed Validcare as ...